Co-Aggregation of Alpha-Synuclein with Amylin(HIAPP) Leads to an Increased Risk in Type ii Diabetes Patients for Developing Parkinson's Disease

Yoav Atsmon-Raz, Yifat Miller

Research output: Contribution to journalMeeting Abstract

Abstract

Clinical studies have reported that Type II diabetes patients (T2D) are more
likely to develop Parkinson’s disease (PD). However, the mechanisms which
link these two diseases have remained elusive. In T2D, Amylin forms aggregates in the pancreas. However, it can also form neurotoxic oligomers in the brain.
Original languageEnglish
Pages (from-to)524A-524A
Number of pages1
JournalBiophysical Journal
Volume108
Issue number2
DOIs
StatePublished - Jan 2015

Fingerprint

Dive into the research topics of 'Co-Aggregation of Alpha-Synuclein with Amylin(HIAPP) Leads to an Increased Risk in Type ii Diabetes Patients for Developing Parkinson's Disease'. Together they form a unique fingerprint.

Cite this